Banque Pictet & Cie Sa Amgen Inc Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $644,524 - $762,136	-3,008 Reduced 60.04%	2,002 $444,000
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $1.31 Million - $1.59 Million	-5,789 Reduced 53.61%	5,010 $1.21 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $245,062 - $311,380	1,070 Added 11.0%	10,799 $0
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $1.87 Million - $2.1 Million	-8,310 Reduced 46.07%	9,729 $2.19 Billion
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $1.83 Million - $2.04 Million	7,932 Added 78.48%	18,039 $4.39 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $376,486 - $416,492	1,717 Added 20.46%	10,107 $2.44 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $140,210 - $160,458	705 Added 9.17%	8,390 $1.89 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $2.06 Million - $2.42 Million	-9,717 Reduced 55.84%	7,685 $1.63 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $58,628 - $65,044	-251 Reduced 1.42%	17,402 $4.24 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $3.57 Million - $4.17 Million	-16,108 Reduced 47.71%	17,653 $4.39 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $123,120 - $146,614	-569 Reduced 1.66%	33,761 $7.76 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $12,671 - $14,091	54 Added 0.16%	34,330 $8.73 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $1.99 Million - $2.44 Million	-10,059 Reduced 22.69%	34,276 $8.08 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $150,165 - $199,160	-824 Reduced 1.82%	44,335 $8.99 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $407,747 - $524,096	-2,155 Reduced 4.55%	45,159 $10.9 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $1.11 Million - $1.32 Million	6,349 Added 15.5%	47,314 $9.16 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $245,048 - $287,252	-1,470 Reduced 3.46%	40,965 $7.55 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $1.02 Million - $1.15 Million	-5,644 Reduced 11.74%	42,435 $8.06 Million
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $250,295 - $292,174	1,403 Added 3.01%	48,079 $9.36 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $359,833 - $405,664	1,942 Added 4.34%	46,676 $9.68 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $34,870 - $39,167	210 Added 0.47%	44,734 $8.26 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $241,437 - $282,150	-1,425 Reduced 3.1%	44,524 $7.59 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $6.39 Million - $7.14 Million	37,835 Added 466.29%	45,949 $7.99 Million
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $1.84 Million - $2.1 Million	-11,000 Reduced 57.55%	8,114 $1.51 Million
Q2 2017 Aug 09, 2017	BUY	N/A	19,114	19,114 $3.29 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account